Samsung Biologics' 2.7 trillion won PolyPeptide acquisition progresses with 87.88% tender acceptance

Samsung Biologics' acquisition of PolyPeptide for 2.7 trillion won is progressing smoothly, with the tender offer drawing an 87.88% acceptance rate.

Detected & updated continuously · Source: Nebula